Literature DB >> 5076829

Effect of host immunity on the antigenic strength of primary tumors.

G L Bartlett.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5076829

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  8 in total

Review 1.  Tumor immunogenicity: how far can it be pushed?

Authors:  R T Prehn
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

Review 2.  Immunosuppression and neoplasia. II. Is deficient immunesurveillance the only mechanism by which immunosuppression promotes neoplasia? A speculative review.

Authors:  E Gleichmann; H Gleichmann
Journal:  Klin Wochenschr       Date:  1973-03-15

3.  Influence of immune status of host on immunogenicity of tumors induced with two doses of methylcholanthrene.

Authors:  E M Lawler; R T Prehn
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

4.  Enhanced tumorigenicity of cloned UV-regressor tumor lines following selected in vivo and in vitro manipulations.

Authors:  M K Schmitt; L K Roberts; L C Gahring; R A Daynes
Journal:  Am J Pathol       Date:  1983-12       Impact factor: 4.307

Review 5.  An immune reaction may be necessary for cancer development.

Authors:  Richmond T Prehn
Journal:  Theor Biol Med Model       Date:  2006-02-03       Impact factor: 2.432

6.  Tumor-secific immunity to chemically induced tumors. Evidence for immunologic specificity and shared antigenicity in lymphocyte responses to soluble tumor antigens.

Authors:  J T Frbes; Y Nakaw; R T Smith
Journal:  J Exp Med       Date:  1975-05-01       Impact factor: 14.307

7.  Immunotherapy of primary methylcholanthrene-induced mouse tumours by intratumoral BCG.

Authors:  N Creau-Goldberg; J C Salomon
Journal:  Br J Cancer       Date:  1980-04       Impact factor: 7.640

8.  The induction of enhanced antitumor effect against a nonimmunogenic tumor by highly immunogenic variants obtained by mutagen treatment.

Authors:  R Sainouchi; N Terata; M Kodama
Journal:  Jpn J Cancer Res       Date:  1988-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.